Moderna (MRNA) +9% as Jefferies says the market is nearing short term 'peak RFK negativity'
Tweet Send to a Friend
Jefferies analyst Michael Yee reiterated a Hold rating and $50.00 price target on Moderna (NASDAQ: MRNA).The analyst said: "We hosted ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
